3P Biopharmaceuticals (3P), a Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacturing of biologics,...
Read moreSwiss manufacturer Omya is developing a new mineral solution for greater stability, performance and survival rates of probiotics during formulation...
Read moreThe last year has been a hugely exiting time for pharma with the industry taking centre stage globally. It’s been...
Read moreAhead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma...
Read moreJohnson & Johnson Covid vaccinations can restart, US health regulators said Friday, after the shots' rollout was paused due to...
Read moreLonza, a CDMO partner to the biopharma industry, announced the construction of a new small molecule manufacturing complex at its...
Read moreA clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are...
Read moreThe US FDA has accepted Airway Therapeutics’ Investigational New Drug (IND) application to develop AT-100 (rhSP-D) for treating Covid-19. A...
Read moreINOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from...
Read moreThe University of Oxford has expanded the Comparing Covid-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2) study to include the...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.